Grace Therapeutics, Inc. - Common Stock (GRCE)
Seasonality Analysis
Grace Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
Grace Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | -0.23% | Weak | |
| February | 0.80% | Weak | |
| March | -1.55% | Weak | |
| April | -2.67% | Very Weak | |
| May | 0.59% | Moderate | |
| June | 0.99% | Moderate | |
| July BEST | 12.06% | Weak | |
| August WORST | -14.80% | Very Weak | |
| September | 9.52% | Weak | |
| October | -9.25% | Very Weak | |
| November | -2.27% | Weak | |
| December | 5.33% | Strong |
Grace Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
Grace Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
Grace Therapeutics, Inc. - Common Stock Pattern Scanner
Grace Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About Grace Therapeutics, Inc. - Common Stock (GRCE) Seasonality
Grace Therapeutics, Inc. - Common Stock (GRCE) has been analyzed using 15 years of historical data to identify seasonal patterns. Classified under Stocks, Grace Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Grace Therapeutics, Inc. - Common Stock is historically July, with an average return of 12.06% and a win rate of 50%. Conversely, August tends to be the weakest month, averaging -14.80% return.
Looking at the full calendar year, Grace Therapeutics, Inc. - Common Stock has an average annual return of -1.49% with an overall monthly win rate of 44.0%. Out of 12 months, 6 typically show positive average returns.
The seasonal pattern for Grace Therapeutics, Inc. - Common Stock has a consistency score of 47.6 (Poor), based on 15 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Grace Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy Grace Therapeutics, Inc. - Common Stock (GRCE)?
Historically, July has been the best month for Grace Therapeutics, Inc. - Common Stock, with an average return of 12.06% and a win rate of 50%. However, past performance does not guarantee future results.
What is the worst month for Grace Therapeutics, Inc. - Common Stock (GRCE)?
Based on historical data, August has been the weakest month for Grace Therapeutics, Inc. - Common Stock, with an average return of -14.80%. This is a historical observation and does not guarantee future results.
How reliable is GRCE seasonality data?
The seasonality analysis for Grace Therapeutics, Inc. - Common Stock is based on 15 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Grace Therapeutics, Inc. - Common Stock seasonality in my trading?
Use Grace Therapeutics, Inc. - Common Stock (GRCE) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.